Advertisement
St. Jude Medical
Subscribe to St. Jude Medical
View Sample

FREE Email Newsletter

St. Jude Medical Gains CE Mark for 25 mm Portico Transcatheter Aortic Heart Valve

December 12, 2013 8:00 am | by The Associated Press | News | Comments

St. Jude Medical, Inc., a global medical device company, has received European CE Mark approval for its 25 mm Portico Transcatheter Aortic Heart Valve Implantation System. The approval expands the number of patients who can be treated using...

Federal Court Shuts Down Janzen Patent Infringement Claim Against AccessClosure

December 11, 2013 7:00 am | by Business Wire | News | Comments

AccessClosure Inc., the market leader in extravascular closure devices, has announced that the U.S. Court of Appeals for the Federal Circuit denied a request by St. Jude Medical Inc. to rehear an appeal on a double patenting ruling concerning...

St. Jude Medical halts Enlightn IV trial

December 10, 2013 3:30 pm | by Mass Device | News | Comments

St. Jude Medical is calling off the Enlightn IV trial of the next generation of its renal denervation technology, just a few months after it began. The trial of St. Jude's multi-electrode Enlightn device was slated to enroll about 590 patients...

Advertisement

St. Jude Medical Board of Directors Authorizes $700 Million Share Repurchase

December 9, 2013 4:25 pm | by Business Wire | News | Comments

St. Jude Medical, Inc. announced today that its Board of Directors has authorized a share repurchase of up to $700 million of its outstanding common stock. The repurchases will occur at such times and at such prices as the management of the...

St. Jude Medical Begins US Study to Evaluate Combination of Peripheral Nerve Field Stimulation and Spinal Cord Stimulation for Chronic Low Back and Leg Pain

December 4, 2013 8:00 am | by Business Wire | News | Comments

St. Jude Medical, Inc., a global medical device company, has launched a clinical study to evaluate the combination of peripheral nerve field stimulation (PNfS), and spinal cord stimulation (SCS), to determine whether the two therapies together...

St. Jude Medical Launches US Study of New Prodigy Neurostimulator to Evaluate Burst Stimulation Technology for Chronic Pain

December 3, 2013 8:00 am | by Business Wire | News | Comments

St. Jude Medical, Inc., a global medical device company, has initiated a clinical study of the Prodigy ™ neurostimulator, the first spinal cord stimulation (SCS) system able to deliver a proprietary mode of stimulation therapy called burst...

St. Jude Medical Reports Positive Clinical Outcomes from Portico Heart Valve Study

October 28, 2013 9:37 pm | by Business Wire | News | Comments

St. Jude Medical, Inc., a global medical device company, today announced positive results for the 23 and 25 mm Portico Transcatheter Aortic Heart Valves in the Portico Transfemoral CE Mark Trial. Patients enrolled in the study experienced a...

New Data from St. Jude Medical Study of EnligHTN Renal Denervation System Presented

October 28, 2013 9:22 pm | by Business Wire | News | Comments

St. Jude Medical, Inc., a global medical device company, today announced new results from the EnligHTN I study, confirming safe, rapid and sustained reduction in blood pressure measurements a year and a half post-procedure. Data presented at...

Advertisement

TCT 2013: Renal denervation does everything

October 28, 2013 4:35 pm | by Mass Device | News | Comments

Renal denervation may have lost some of its hype over the course of the last year, but researchers are still findings new ways to utilize the technology to target new diseases. Technologies such as Medtronic's Symplicity and St. Jude Medical's...

St. Jude Medical seeks to toss shareholders class action

October 17, 2013 3:59 pm | by Mass Device | News | Comments

St. Jude Medical wants a federal judge in Minnesota to toss a class action lawsuit filed by shareholders after the medical device company's stock took a dive in 2009 when it reduced its guidance. The lawsuit, filed in March 2010, alleges that St. Jude...

Rare Serious Erosion Events Associated with St. Jude Amplatzer Atrial Septal Occluder (ASO)

October 17, 2013 12:00 am | by U.S. Food & Drug Administration | News | Comments

The St. Jude Amplatzer Atrial Septal Occluder is a cardiac implant device used in children and adults to treat an abnormal hole between the upper left and right chambers of the heart, known as an atrial septal defect. The metal device is put...

St. Jude Gets EU Approval for Wireless Pacemaker

October 14, 2013 12:02 am | by The Associated Press | News | Comments

St. Jude Medical says it will announce Monday that it received European approval to market the first pacemaker that does not require wires to attach to the heart. The first-of-a-kind device was developed by California-based startup, Nanostim...

St. Jude CEO Starks snarks rivals' 'lack of imagination'

October 11, 2013 2:39 pm | by Mass Device | News | Comments

St. Jude Medical (NYSE:STJ) CEO Daniel Starks has his own key to success, and it doesn't jibe well with some of his rivals, who he left unnamed in his criticism. Starks told an audience at the Minnesota Venture Finance Conference this week...

Advertisement

Appeals court reverses St. Jude Medical win over Access Closure

September 12, 2013 2:10 pm | by Mass Device | News | Comments

A federal appeals court overturned a portion of a legal win for St. Jude Medical yesterday, ruling that a lower court erred in invoking the "safe harbor" provision against double-patenting claims in a patent infringement lawsuit against Access Closure Inc.

St. Jude’s New Renal Denervation System Reduces Total Ablation Time by More Than 80%

August 29, 2013 10:51 am | by Business Wire | News | Comments

St. Jude Medical, Inc., a global medical device company, today announced the CE Mark approval of its next-generation EnligHTN Renal Denervation System for treating patients with drug-resistant, uncontrolled hypertension. The system features an advanced generator that delivers simultaneous ablations via a multi-electrode catheter...

GPOs: Medtronic, St. Jude, Boston Scientific land new deals from Premier

August 13, 2013 12:27 pm | by Mass Device | News | Comments

Premier Healthcare Alliance awarded several new contracts for drug-eluting stents, traditional stents and other intervention products to 8 heavy hitters in the cardiology space. Abbott, Boston Scientific, and Medtronic all landed supplier deals for drug-eluting and traditional stents.

St. Jude Medical Launches Wireless MRI-Conditional Pacemaker in Japan

June 27, 2013 8:01 am | by Business Wire | News | Comments

St. Jude Medical, Inc. (NYSE:STJ), a global medical device company, today announced regulatory approval from the Japanese Ministry of Health, Labor and Welfare (MHLW) and launch of the Accent MRI ™ Pacemaker and the Tendril MRI ™ lead.   

St. Jude Medical Receives CE Mark Approval of MultiPoint Pacing CRT-D

June 24, 2013 8:00 am | by Business Wire | News | Comments

St. Jude Medical, Inc., a global medical device company, today announced CE Mark approval of its next-generation quadripolar device, the Quadra Assura MP ™ cardiac resynchronization therapy defibrillator (CRT-D). Built upon the company’s first-to-market Quadripolar Pacing System, the Quadra Assura MP CRT-D features MultiPoint ™ Pacing (MPP) technology that enables physicians to pace multiple locations on the left side of the heart.

High-Voltage Devices from St. Jude Medical Get FDA Approval

June 18, 2013 1:46 pm | by St. Jude Medical | News | Comments

St. Jude Medical (NYSE:STJ) has announced U.S. Food and Drug Administration (FDA) approval of its next-generation Ellipse and SJM Assura portfolio of implantable cardioverter defibrillators (ICDs) and cardiac resynchronization therapy defibrillators (CRT-Ds). The new devices are designed to lower the risk of lead abrasion and to ensure high-voltage therapy delivery.

Approval Of Boston Scientific's Watchman Device Will Support Rapid Growth In The Global Heart Defect Closure Device Market

June 12, 2013 8:00 am | by The Associated Press | News | Comments

According to Millennium Research Group (MRG), the global authority on medical technology market intelligence, the anticipated Food and Drug Administration (FDA) approval of Boston Scientific's WATCHMAN device will drive rapid growth in the market for global heart defect closure devices. ...

St. Jude Medical Announces FDA Approval of High-Voltage Devices with New Safety Features

June 11, 2013 4:05 pm | by Business Wire | News | Comments

St. Jude Medical, Inc. (NYSE:STJ), a global medical device company, today announced U.S. Food and Drug Administration (FDA) approval of its next-generation Ellipse™ and SJM Assura™ portfolio of implantable cardioverter defibrillators (ICDs) and cardiac resynchronization therapy defibrillators (CRT-Ds). The new devices are designed to lower the risk of lead abrasion and to ensure high-voltage therapy delivery.

St. Jude Medical Signs Equity Investment and Option to Purchase Agreement with Spinal Modulation

June 7, 2013 11:01 am | by Business Wire | News | Comments

St. Jude Medical, Inc., a global medical device company, and privately-held Spinal Modulation, Inc., today announced that they have entered into a series of agreements under which St. Jude Medical made a $40 million equity investment in Spinal Modulation, a company that has developed an innovative neuromodulation therapy that provides a new pain management option for patients with chronic, intractable pain.

St. Jude Medical Initiates First US Clinical Study of the EnligHTN Renal Denervation System for Drug-Resistant High Blood Pressure

June 4, 2013 8:00 am | by Business Wire | News | Comments

St. Jude Medical, Inc. (NYSE:STJ), a global medical device company, today announced U.S. Food and Drug Administration (FDA) approval to begin the EnligHTN IV Renal Denervation Study, the first U.S. trial using the EnligHTN ™ Multi-Electrode Renal Denervation System to treat patients with drug-resistant high blood pressure.

One Year Data from St. Jude Medical Study Demonstrates Safe, Rapid and Sustained Blood Pressure Reduction with EnligHTN Renal Denervation Technology

May 23, 2013 4:15 am | by The Associated Press | News | Comments

ST. PAUL, Minn. & PARIS--(BUSINESS WIRE)--May 23, 2013--St. Jude Medical, Inc. (NYSE:STJ), a global medical device company, today announced that the company’s EnligHTN ™ Multi-Electrode Renal Denervation System provides a safe, rapid and sustained reduction in blood pressure measurements after...

St. Jude Medical EnligHTNment Study Highlighted at EuroPCR During Trials That May Change Clinical Practice Session

May 21, 2013 9:52 am | by The Associated Press | News | Comments

ST. PAUL, Minn. & PARIS--(BUSINESS WIRE)--May 21, 2013--St. Jude Medical, Inc. (NYSE:STJ), a global medical device company, today announced the start of its landmark EnligHTNment clinical study. This is the largest randomized, prospective trial to determine whether renal denervation and...

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading